SCHEMBL20549697

SCHEMBL20549697

Cc1ccc2c(c1)c1c(n2CC2CO2)CCN(C(=O)O)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 8/20 0.58
PTGDR Q13258 1/20 0.52
BAZ2B Q9UIF8 2/20 0.47
ADRA2A P08913 2/20 0.47
HTR2A P28223 2/20 0.47
HTR2C P28335 2/20 0.47
HTR7 P34969 2/20 0.47
ADRA1A P35348 2/20 0.47
HRH1 P35367 2/20 0.47
HTR6 P50406 2/20 0.47
DRD2 P14416 1/20 0.47
AKR1B10 O60218 1/20 0.46
AKR1B1 P15121 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
GRIN2D O15399 2/20 0.45
GRIN3B O60391 2/20 0.45
GRIN1 Q05586 2/20 0.45
GRIN2A Q12879 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL409544 0.89 AKR1B10 (0.58) PTGDR2PTGDRBAZ2BADRA2AHTR2A
SCHEMBL13142326 0.80 HRH1 (0.74) PTGDR2PTGDRADRA2AHTR2AHTR2C
SCHEMBL3425662 0.75 HRH1 (0.75) PTGDR2PTGDRADRA2AHTR2AHTR2C
SCHEMBL3087175 0.73 PTGDR2 (1.00) PTGDR2PTGDRBAZ2B
SCHEMBL410245 0.72 MAPT (0.65) ADRA2AHTR2AHTR2CHTR7ADRA1A
SCHEMBL3083804 0.72 PTGDR2 (0.68) PTGDR2PTGDRBAZ2BAKR1B10AKR1B1
SCHEMBL2243442 0.71 PTGDR2 (0.59) PTGDR2PTGDRHDAC1HDAC6
SCHEMBL3316702 0.71 PTGDR2 (0.69) PTGDR2PTGDRBAZ2BADRA2AHTR2A
SCHEMBL3024366 0.71 HTR6 (0.73) PTGDR2PTGDRBAZ2BADRA2AHTR2A
SCHEMBL3024370 0.71 HTR6 (0.73) PTGDR2PTGDRBAZ2BADRA2AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180318255-A1 Pro-Neurogenic Compounds BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2018-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180318255-A1 Pro-Neurogenic Compounds BDNF, GAP43, DCX PTGDR2 566/4885PTGDR 308/4885BAZ2B 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.